Shigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122
Clinical trial NCT04634513 · COMPLETED
Trial details
- NCT number
- NCT04634513
- Sponsor
- University of Maryland, Baltimore
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-29
- Primary completion
- 2024-10-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.